Insider trade

Officer sold ~$15K of BDX shares in the open market

Traded Jan 26, 2026 · Filed Jan 28, 2026

Becton DickinsonBDX

~$15K
Reported value · 75 sh @ $202.73: 16K
Holds after · shares reported: -12.5%
stock since the trade · S&P 500 +10.3%, $203.42 → $178.07 on Oct 1

Why it stands out

Becton Dickinson's CRO & Pres. Life Sciences sold $15K of Becton Dickinson shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jan 26, 2026
Reporting period: Not applicable
Filed with the SEC: Jan 28, 2026

Officer<$25K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$15,205

Shares × reported transaction price

Timing vs results

81 days after results of Nov 6, 2025, 14 days before results of Feb 9, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $203.42 on Jan 26, 2026, 23% above its 52-week low and 18% below its high, after a 3% rise over the previous 30 trading days

52-week range $165.15 (May 6, 2025) to $249.08 (Jan 28, 2025), 46% of the way up, from 251 adjusted closes. 30 trading days earlier: $198.40 on Dec 10, 2025. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+2.7%	-2.4%	+5.1%
30 days	-12.2%	-1.1%	-11.1%
90 days	-27.7%	+2.5%	-30.3%
180 days	-17.3%	+6.8%	-24.0%

Past results only. Not a forecast.

Source receipt

Record ID: 0001628280-26-003734
Filed / recorded: Jan 28, 2026, 2:46 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: BECTON DICKINSON & CO
Issuer CIK: 10795
Ticker: BDX
Reporting person: Michael Feld
Relationship: Officer
Officer title: EVP, CRO & Pres. Life Sciences
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Jan 26, 2026
Transaction code: S
Shares / units: 75
Price per share: $202.73
Acquired / disposed: Disposed (D)
Shares owned after: 16,431
Ownership form: Direct
Amendment: No

Around the same time

Officer sold ~$14K of Becton Dickinson

Automatic sale7mo ago

Director sold8mo ago

~$174KReported value · 953 sh @ $182.61

A board member of Becton Dickinson sold $174K of Becton Dickinson shares. Nobody planned it ahead of time.

Why it stands out Official record

8mo ago

100Derivative units · @ $201.91

Compensation award — excluded from discretionary-purchase analysis.

Why it stands out Official record